Population-based studies in Sweden suggest that COVID-19 is an independent risk factor for acute myocardial infarction and ischemic stroke.
COVID-19 is associated with cardiovascular and thrombotic complications. However, questions remain about the magnitude of the risk and which patients have the highest risk. Therefore, Swedish investigators undertook a self-controlled case series (in which the case also acts as the control) and matched cohort study (for a comparison with the background population) to define the risks for acute myocardial infarction (AMI) and ischemic stroke after COVID-19 onset.
The researchers analyzed records of all 86,742 people diagnosed with COVID-19 in Sweden from February 1 to September 14, 2020, which they linked with national inpatient, outpatient, cancer, and death registries. For the matched cohort study, they identified 348,481 controls, matched b…
Reviewing Author
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association